What does NEW PHARMACIE SAINT ANTOINE do?

NEW PHARMACIE SAINT ANTOINE is a pharmacy in Etterbeek. Private Limited, started on 22 December 2020, 1 establishment.

What is the address of NEW PHARMACIE SAINT ANTOINE?

The registered office of NEW PHARMACIE SAINT ANTOINE is located at Sint-Antoonplein 44, 1040 Etterbeek.

Is NEW PHARMACIE SAINT ANTOINE still active?

Yes. According to the CBE (2 October 2026) NEW PHARMACIE SAINT ANTOINE is active, legal situation “Normale toestand”, started on 22 December 2020.

Is NEW PHARMACIE SAINT ANTOINE registered on Peppol?

Yes, NEW PHARMACIE SAINT ANTOINE is registered on the Peppol network with ID 0208:0760424768.

What is the enterprise number of NEW PHARMACIE SAINT ANTOINE?

The enterprise number of NEW PHARMACIE SAINT ANTOINE is BE0760424768.

When was NEW PHARMACIE SAINT ANTOINE founded?

NEW PHARMACIE SAINT ANTOINE was founded on 22 December 2020.

Who are the directors of NEW PHARMACIE SAINT ANTOINE?

According to the 2025 annual accounts, the directors of NEW PHARMACIE SAINT ANTOINE are: FABRICE SOILLE, MORGANE VAN de STADT, VINCENT BIERLAIRE.

Is NEW PHARMACIE SAINT ANTOINE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2020; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did NEW PHARMACIE SAINT ANTOINE make in 2025?

NEW PHARMACIE SAINT ANTOINE posted a profit after taxes of € 22,128 in financial year 2025.

What is the revenue of NEW PHARMACIE SAINT ANTOINE?

As a small company, NEW PHARMACIE SAINT ANTOINE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 294,617.

How much does an employee at NEW PHARMACIE SAINT ANTOINE earn?

The average wage cost per full-time employee at NEW PHARMACIE SAINT ANTOINE was € 56,400 in 2025: staff costs of € 157,878 for 2.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does NEW PHARMACIE SAINT ANTOINE have?

According to the 2025 annual accounts, NEW PHARMACIE SAINT ANTOINE has 2.8 full-time equivalents (FTE).

NEW PHARMACIE SAINT ANTOINE (Private Limited) - Etterbeek

Dossier NEW PHARMACIE SAINT ANTOINE, printed on 2 October 2026 from databakkes.be/en/0760424768/new-pharmacie-saint-antoine. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 33 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

NEW PHARMACIE SAINT ANTOINE from Etterbeek, company number BE0760424768, closed financial year 2025 with a result of € 22,128 after tax. For that financial year NEW PHARMACIE SAINT ANTOINE recorded a gross margin of € 294,617 and equity of € 38,882. Compared with financial year 2024, the result moved from € -16,372 to € 22,128. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 38,882

▲ 132% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 22,128

▲ still € 16,372 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 70,805

▲ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -11,118.

People and assets in 2025

Full-time equivalents

2.8

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 157,878

▼ 13% vs 2024

€ 56,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 28,672

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 424,939

▼ 17% vs 2024

€ 81,788 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 125,605

▲ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 24,554

▲ 38% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 269,777 Gross margin 2022: € 269,777 First fiscal year in the series	€ 259,341 Gross margin 2023: € 259,341 ▼ 4% vs 2022 (€ 269,777) Unfavourable step	€ 285,260 Gross margin 2024: € 285,260 ▲ 10% vs 2023 (€ 259,341) Favourable step	€ 294,617 Gross margin 2025: € 294,617 ▲ 3% vs 2024 (€ 285,260) Favourable step	▲ 3%
Profit after taxes	€ 1,327 Profit after taxes 2022: € 1,327 First fiscal year in the series	€ -36,038 Profit after taxes 2023: € -36,038 ▼ € 37,365 vs 2022 (€ 1,327) Unfavourable step	€ -16,372 Profit after taxes 2024: € -16,372 ▲ € 19,666 vs 2023 (€ -36,038) Favourable step	€ 22,128 Profit after taxes 2025: € 22,128 ▲ € 38,500 vs 2024 (€ -16,372) Favourable step	▲ € 38,500
Equity	€ 69,164 Equity 2022: € 69,164 First fiscal year in the series	€ 33,126 Equity 2023: € 33,126 ▼ 52% vs 2022 (€ 69,164) Unfavourable step	€ 16,754 Equity 2024: € 16,754 ▼ 49% vs 2023 (€ 33,126) Unfavourable step	€ 38,882 Equity 2025: € 38,882 ▲ 132% vs 2024 (€ 16,754) Favourable step	▲ 132%
Total debts	€ 844,478 Total debts 2022: € 844,478 First fiscal year in the series	€ 754,923 Total debts 2023: € 754,923 ▼ 11% vs 2022 (€ 844,478) Favourable step	€ 702,887 Total debts 2024: € 702,887 ▼ 7% vs 2023 (€ 754,923) Favourable step	€ 663,001 Total debts 2025: € 663,001 ▼ 6% vs 2024 (€ 702,887) Favourable step	▼ 6%
Cash	€ 88,577 Cash 2022: € 88,577 First fiscal year in the series	€ 32,065 Cash 2023: € 32,065 ▼ 64% vs 2022 (€ 88,577) Unfavourable step	€ 55,913 Cash 2024: € 55,913 ▲ 74% vs 2023 (€ 32,065) Favourable step	€ 70,805 Cash 2025: € 70,805 ▲ 27% vs 2024 (€ 55,913) Favourable step	▲ 27%
Retained profit	€ 19,164 Retained profit 2022: € 19,164 First fiscal year in the series	€ -16,874 Retained profit 2023: € -16,874 ▼ € 36,038 vs 2022 (€ 19,164) Unfavourable step	€ -33,246 Retained profit 2024: € -33,246 ▼ € 16,372 vs 2023 (€ -16,874) Unfavourable step	€ -11,118 Retained profit 2025: € -11,118 ▲ € 22,128 vs 2024 (€ -33,246) Favourable step	▲ € 22,128
Bank debt	€ 684,237 Bank debt 2022: € 684,237 First fiscal year in the series	€ 598,492 Bank debt 2023: € 598,492 ▼ 13% vs 2022 (€ 684,237) Favourable step	€ 512,171 Bank debt 2024: € 512,171 ▼ 14% vs 2023 (€ 598,492) Favourable step	€ 424,939 Bank debt 2025: € 424,939 ▼ 17% vs 2024 (€ 512,171) Favourable step	▼ 17%
Balance sheet total	€ 913,642 Balance sheet total 2022: € 913,642 First fiscal year in the series	€ 788,048 Balance sheet total 2023: € 788,048 ▼ 14% vs 2022 (€ 913,642) Unchanged	€ 719,641 Balance sheet total 2024: € 719,641 ▼ 9% vs 2023 (€ 788,048) Unchanged	€ 701,883 Balance sheet total 2025: € 701,883 ▼ 2% vs 2024 (€ 719,641) Unchanged	▼ 2%
Employees (FTE)	2.9 Employees (FTE) 2022: 2.9 First fiscal year in the series	2.9 Employees (FTE) 2023: 2.9 Unchanged (2.9) Unchanged	2.9 Employees (FTE) 2024: 2.9 Unchanged (2.9) Unchanged	2.8 Employees (FTE) 2025: 2.8 ▼ 0.1 vs 2024 (2.9) Unchanged	▼ 0.1

Key figures of NEW PHARMACIE SAINT ANTOINE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NEW PHARMACIE SAINT ANTOINE?

What happened at NEW PHARMACIE SAINT ANTOINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 22,128. filed late Source: NBB ↗
Jan 1, 2021 New establishment in Etterbeek. KBO
Dec 22, 2020 Start of the company according to the CBE. KBO

In short

From € 1,327 profit in 2022 to € 22,128 profit in 2025.

Paid € 1,929 in corporate taxes since 2022.

Best year ever: 2025, with € 22,128 profit.

On average € 105,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at NEW PHARMACIE SAINT ANTOINE? We notify you, reason included.

Follow NEW PHARMACIE SAINT ANTOINE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

FABRICE SOILLE MORGANE VAN de STADT VINCENT BIERLAIRE

NEW PHARMACIE SAINT ANTOINE

XLENCE PHARMA

IMMO SAINT ANTOINE

Behind NEW PHARMACIE SAINT ANTOINE are FABRICE SOILLE, MORGANE VAN de STADT and VINCENT BIERLAIRE. MORGANE VAN de STADT is also behind XLENCE PHARMA. VINCENT BIERLAIRE is also behind IMMO SAINT ANTOINE.

See the full network in the app

Directors

According to the 2025 annual accounts

FABRICE SOILLE

Managing director

MORGANE VAN de STADT

Director

Also active at: XLENCE PHARMA

VINCENT BIERLAIRE

Managing director

Also active at: IMMO SAINT ANTOINE

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Antoonplein 44

1040 Etterbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

IMMO SAINT ANTOINE same network

€ 55,048 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0760.424.768
VAT number: BE 0760.424.768
Registered office: Sint-Antoonplein 44, 1040 Etterbeek
Names & denominations: NEW PHARMACIE SAINT ANTOINE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 December 2020
Peppol: Active · Active since 13 Jun 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗